Related Experiment Video
Updated: May 7, 2026
10:10
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
Theranostic immunoliposomes for osteoarthritis.
Hongsik Cho1, John M Stuart2, Richard Magid3
1University of Tennessee Health Science Center, Memphis, TN, USA; Campbell Clinnic, Memphis, TN, USA; Veterans Affairs Medical Center, Memphis, TN, USA.
Nanomedicine : Nanotechnology, Biology, and Medicine
|October 8, 2013
Summary
New near-infrared immunoliposomes target damaged cartilage for early osteoarthritis (OA) diagnosis and treatment. This innovative tool aids in monitoring disease progression and evaluating therapeutic effectiveness in preclinical models.
Area of Science:
- Biomedical Engineering
- Immunology
- Osteoarthritis Research
Background:
- Current osteoarthritis (OA) treatments are largely palliative, necessitating joint replacement.
- Early diagnosis and monitoring are crucial for effective OA therapy, but current tools are limited.
- Developing preventive strategies for OA is hindered by a lack of efficient diagnostic and progression monitoring methods.
Purpose of the Study:
- To develop novel near-infrared (NIR) immunoliposomes for early diagnosis and treatment of osteoarthritis (OA).
- To create a tool for quantifying type II collagen exposure during cartilage degradation in vivo.
- To assess the potential of these immunoliposomes as diagnostic agents and drug delivery vehicles for OA.
Main Methods:
- Conjugation of near-infrared fluorescent dyes to liposomes.
- Antibody targeting of type II collagen on damaged cartilage.
- In vivo imaging and quantification of cartilage degradation in a guinea pig model.
- Evaluation of immunoliposomes for localized drug delivery.
Main Results:
- Developed NIR immunoliposomes conjugated with type II collagen antibody.
- Demonstrated specific binding of immunoliposomes to damaged cartilage, not normal cartilage.
- Successfully quantified type II collagen exposure in vivo in a guinea pig model.
- Showcased potential for monitoring therapeutic intervention effectiveness and localized drug delivery.
Conclusions:
- NIR immunoliposomes offer a promising tool for early OA diagnosis and monitoring.
- These immunoliposomes can quantify cartilage degradation by measuring type II collagen exposure.
- The developed technology serves as a potential vehicle for targeted drug delivery to OA chondrocytes.
- This approach could significantly advance the development of preventive therapies for osteoarthritis.
